对5-氨基水杨酸栓剂过敏。 - Suppr

Suppr

超能文献

Hypersensitivity to 5-ASA suppositories.

作者信息

Borum M L, Ginsberg A

机构信息

Division of Gastroenterology and Nutrition, The George Washington University Medical Center, Washington, DC 20037, USA.

出版信息

Dig Dis Sci. 1997 May;42(5):1076-8. doi: 10.1023/a:1018857607739.

DOI:10.1023/a:1018857607739

PMID:9149065

Abstract

摘要

相似文献

Hypersensitivity to 5-ASA suppositories.

Dig Dis Sci. 1997 May;42(5):1076-8. doi: 10.1023/a:1018857607739.

Pleuropericarditis related to the use of mesalamine.

Dig Dis Sci. 1996 Mar;41(3):624-6. doi: 10.1007/BF02282352.

Leukopenia and thrombocytopenia as adverse effects of treatment with 5-aminosalicylic suppositories.

J Clin Gastroenterol. 1996 Mar;22(2):160-1. doi: 10.1097/00004836-199603000-00023.

[The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid].

Ter Arkh. 1996;68(2):75-7.

Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.

J Clin Gastroenterol. 1997 Jan;24(1):34-6. doi: 10.1097/00004836-199701000-00007.

Hypersensitivity to 5-ASA suppositories.

Dig Dis Sci. 1999 Dec;44(12):2552-3. doi: 10.1023/a:1026611827653.

Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Dig Dis Sci. 1999 Aug;44(8):1600. doi: 10.1023/a:1026667027827.

Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.

Aliment Pharmacol Ther. 1997 Apr;11(2):335-40. doi: 10.1046/j.1365-2036.1997.126297000.x.

5-aminosalicylates in inflammatory bowel disease--the more the merrier?

Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1017-9. doi: 10.1097/00042737-199511000-00001.

[Mesalazine old and new].

Gastroenterol Hepatol. 2011 Dec;34 Suppl 3:25-9. doi: 10.1016/S0210-5705(11)70095-4. Epub 2014 Oct 30.

引用本文的文献

Acute eosinophilic pneumonia related to a mesalazine suppository.

Asia Pac Allergy. 2013 Apr;3(2):136-9. doi: 10.5415/apallergy.2013.3.2.136. Epub 2013 Apr 26.

Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Dig Dis Sci. 2002 Feb;47(2):469. doi: 10.1023/a:1013715415778.

Hypersensitivity to 5-ASA suppositories.

Dig Dis Sci. 1999 Dec;44(12):2552-3. doi: 10.1023/a:1026611827653.

Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Dig Dis Sci. 1999 Aug;44(8):1600. doi: 10.1023/a:1026667027827.

Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Dig Dis Sci. 1999 Jul;44(7):1494. doi: 10.1023/a:1026676407838.

本文引用的文献

Interstitial nephritis associated with 5-aminosalicylic acid.

Nephron. 1994;67(4):481-2. doi: 10.1159/000188024.

Mesalazine induced interstitial nephritis.

Gut. 1994 Oct;35(10):1493-6. doi: 10.1136/gut.35.10.1493.

Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas.

Digestion. 1984;29(4):231-4. doi: 10.1159/000199038.

A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis.

Digestion. 1984;29(4):204-8. doi: 10.1159/000199034.

Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.

Dig Dis Sci. 1983 Jul;28(7):609-15. doi: 10.1007/BF01299921.

5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine.

Lancet. 1984 Feb 18;1(8373):403. doi: 10.1016/s0140-6736(84)90462-8.

Sulfasalazine. Adverse effects and desensitization.

Dig Dis Sci. 1983 Sep;28(9):833-42. doi: 10.1007/BF01296907.

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Lancet. 1981 Aug 8;2(8241):270-1. doi: 10.1016/s0140-6736(81)90523-7.

Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

South Med J. 1968 Apr;61(4):354-8. doi: 10.1097/00007611-196804000-00005.

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

N Engl J Med. 1973 Sep 6;289(10):491-5. doi: 10.1056/NEJM197309062891001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Hypersensitivity to 5-ASA suppositories.

Dig Dis Sci. 1997 May;42(5):1076-8. doi: 10.1023/a:1018857607739.

Pleuropericarditis related to the use of mesalamine.

Dig Dis Sci. 1996 Mar;41(3):624-6. doi: 10.1007/BF02282352.

Leukopenia and thrombocytopenia as adverse effects of treatment with 5-aminosalicylic suppositories.

J Clin Gastroenterol. 1996 Mar;22(2):160-1. doi: 10.1097/00004836-199603000-00023.

[The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid].

Ter Arkh. 1996;68(2):75-7.

Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.

J Clin Gastroenterol. 1997 Jan;24(1):34-6. doi: 10.1097/00004836-199701000-00007.

Hypersensitivity to 5-ASA suppositories.

Dig Dis Sci. 1999 Dec;44(12):2552-3. doi: 10.1023/a:1026611827653.

Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Dig Dis Sci. 1999 Aug;44(8):1600. doi: 10.1023/a:1026667027827.

Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.

Aliment Pharmacol Ther. 1997 Apr;11(2):335-40. doi: 10.1046/j.1365-2036.1997.126297000.x.

5-aminosalicylates in inflammatory bowel disease--the more the merrier?

Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1017-9. doi: 10.1097/00042737-199511000-00001.

[Mesalazine old and new].

Gastroenterol Hepatol. 2011 Dec;34 Suppl 3:25-9. doi: 10.1016/S0210-5705(11)70095-4. Epub 2014 Oct 30.

引用本文的文献

Acute eosinophilic pneumonia related to a mesalazine suppository.

Asia Pac Allergy. 2013 Apr;3(2):136-9. doi: 10.5415/apallergy.2013.3.2.136. Epub 2013 Apr 26.

Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Dig Dis Sci. 2002 Feb;47(2):469. doi: 10.1023/a:1013715415778.

Hypersensitivity to 5-ASA suppositories.

Dig Dis Sci. 1999 Dec;44(12):2552-3. doi: 10.1023/a:1026611827653.

Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Dig Dis Sci. 1999 Aug;44(8):1600. doi: 10.1023/a:1026667027827.

Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Dig Dis Sci. 1999 Jul;44(7):1494. doi: 10.1023/a:1026676407838.

本文引用的文献

Interstitial nephritis associated with 5-aminosalicylic acid.

Nephron. 1994;67(4):481-2. doi: 10.1159/000188024.

Mesalazine induced interstitial nephritis.

Gut. 1994 Oct;35(10):1493-6. doi: 10.1136/gut.35.10.1493.

Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas.

Digestion. 1984;29(4):231-4. doi: 10.1159/000199038.

A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis.

Digestion. 1984;29(4):204-8. doi: 10.1159/000199034.

Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.

Dig Dis Sci. 1983 Jul;28(7):609-15. doi: 10.1007/BF01299921.

5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine.

Lancet. 1984 Feb 18;1(8373):403. doi: 10.1016/s0140-6736(84)90462-8.

Sulfasalazine. Adverse effects and desensitization.

Dig Dis Sci. 1983 Sep;28(9):833-42. doi: 10.1007/BF01296907.

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Lancet. 1981 Aug 8;2(8241):270-1. doi: 10.1016/s0140-6736(81)90523-7.

Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

South Med J. 1968 Apr;61(4):354-8. doi: 10.1097/00007611-196804000-00005.

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

N Engl J Med. 1973 Sep 6;289(10):491-5. doi: 10.1056/NEJM197309062891001.